Literature DB >> 15207785

Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.

Helga-Paula Török1, Jürgen Glas, Laurian Tonenchi, Thomas Mussack, Christian Folwaczny.   

Abstract

Genes encoding for receptors of the innate immune system are potential candidates for susceptibility to inflammatory bowel disease, e.g., mutations in the cytosolic receptor NOD2/CARD15 were associated with Crohn's disease. Herein, two mutations of the Toll-like receptor (TLR)-4 gene (Asp299Gly and Thr399Ile) resulting in impaired lipopolysaccharide signaling, the -159C/T promotor polymorphism of the CD14 gene, polymorphisms of the lipopolysaccharide binding protein gene and the bactericidal permeability increasing protein gene were evaluated in 102 patients with Crohn's disease, 98 patients with ulcerative colitis and 145 healthy controls. The allele and carrier frequencies for the Thr399Ile mutation in TLR4 gene were significantly increased in ulcerative colitis when compared to the controls (P = 0.014 and P = 0.018, respectively). None of the other five polymorphisms was associated with inflammatory bowel disease. In conclusion, a novel association between a functional polymorphism in TLR4 and ulcerative colitis is reported. This observation underscores the importance of impaired innate immunity in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207785     DOI: 10.1016/j.clim.2004.03.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  69 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

2.  DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.

Authors:  C L Noble; E R Nimmo; H Drummond; L Smith; I D R Arnott; J Satsangi
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

Review 3.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 4.  [Molecular therapy in gastroenterology and hepatology].

Authors:  J Wedemeyer; N P Malek; M P Manns; M J Bahr
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

5.  Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe.

Authors:  I D R Arnott; G-T Ho; E R Nimmo; J Satsangi
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 6.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

7.  TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.

Authors:  R Adam; R D Sturrock; J A Gracie
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

8.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

Review 9.  Role of the intestinal barrier in inflammatory bowel disease.

Authors:  Mike G Laukoetter; Porfirio Nava; Asma Nusrat
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 10.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.